Sotax automated HPLC-dissolution platform

Department of Health and Human Services

Forecast Overview

NAICS
334516
Performance end
1/2026

The purrchase of this instrument enhances OPQ lab testing capability for generic drugs. Replacement of the current Waters Alliance dissolution platform as well as the USP 2 apparatus, which is over 15 years old and no longer supported by the vendor with increasingly difficult parts procurement. This equipment is essential for OPQR laboratory operations to conduct dissolution studies that directly support OPQ mission objectives and research goals, ensuring continued analytical capability for drug product testing. The work performed with this instrument will support GDUFA program needs.

Source

Source
HHS SBCX Forecast Export
Source file
Forecast.csv
Official source
Agency forecast source
Last verified
2026-08-31

Agency-published contact: · TBD@fda.hhs.gov

Related Federal Entities